You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 120 No. 9, September 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Articles
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

p53 Gene Mutations as Markers of Tumor Spread in Synchronous Oral Cancers

Wayne M. Koch, MD; Jay O. Boyle, MD; Li Mao, MD; John Hakim, MD; Ralph H. Hruban, MD; David Sidransky, MD

Arch Otolaryngol Head Neck Surg. 1994;120(9):943-947.


Abstract

Objective
To demonstrate how genetic mutations may be used as specific markers for the study and management of head and neck squamous cell carcinomas.

Design
Mutations in the p53 gene were identified by DNA sequencing in synchronous primary head and neck squamous cell carcinomas from one patient. The polymerase chain reaction and mutant-specific oligomer probes were used to detect rare tumor cells in surgical margins, lymph nodes, and swabs of the oral cavity.

Patient
Selected from a consecutive series of individuals with head and neck squamous cell carcinomas at a tertiary referral center.

Results
Two synchronous primary invasive cancers displayed different missense mutations in the p53 gene. The mutated sequence from one primary tumor was detected in metastases from both sides of the neck. Infiltrating cells from this biologically aggressive tumor were also detected by a polymerase chain reaction–based assay in a histologically normal surgical margin, accurately predicting tumor recurrence.

Conclusions
p53 gene mutations were useful as molecular markers to distinguish between tumors in this case. The potential utility of detection of tumor cells in surgical margins and saliva by molecular techniques merits further investigation.

(Arch Otolaryngol Head Neck Surg. 1994;120:943-947)



Author Affiliations

From the Departments of Otolaryngology–Head and Neck Surgery (Drs Koch, Boyle, Mao, Hakim, and Sidransky) and Pathology (Dr Hruban), The Johns Hopkins University School of Medicine, Baltimore, Md.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Aberrant Promoter Methylation of the Transcription Factor Genes PAX5 {alpha} and {beta} in Human Cancers
Palmisano et al.
Cancer Res. 2003;63:4620-4625.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.